ClinConnect ClinConnect Logo
Search / Trial NCT06764602

Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous Sclerosis

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 7, 2025

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

Tuberous Sclerosis Complex Nephropathy Children

ClinConnect Summary

This clinical trial is studying how often kidney problems occur in children with Tuberous Sclerosis Complex (TSC), a condition that can cause growths in various organs. Researchers are looking at medical records from pediatric patients under 17 years old who were diagnosed with TSC between January 2018 and June 2021. The goal is to better understand how TSC affects the kidneys and to gather important information that could help improve care for these patients.

To participate in this study, children must be under 17 years old at the time of their last medical visit and have been evaluated for TSC during the specified timeframe. Their parents or guardians will need to sign a consent form to allow them to be part of the study. Participants will not need to undergo any new treatments or procedures specifically for this study; instead, researchers will review existing medical records to gather the necessary information. This study is important because it aims to shed light on kidney involvement in TSC, which can help healthcare providers better manage this condition in children.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients of either sex under the age of 17 years at the time of last observation (06/30/2021);
  • Patients clinically evaluated in an outpatient or inpatient setting during 01/01/2018- 30/06/2021 with a diagnosis of TSC;
  • Informed consent signed by parent or legal guardian.
  • Exclusion Criteria:
  • Patients older than 18 years of age;
  • Patients with other phacomatoses.

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Bologna, , Italy

Patients applied

0 patients applied

Trial Officials

Andrea Pasini, MD

Principal Investigator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported